Global Myocardial Infarction Market to Witness Upward Trend with Evidence of Myocardial Injury Common among Covid-19 Patients
Market Overview:
A myocardial infarction, commonly known as a heart attack, occurs when blood flow decreases or stops to the coronary artery of the heart. It is characterized by an extended subclinical phase leading to the sudden onset of life-threatening acute events ST segment elevation, myocardial infarction, non-ST segment elevation, myocardial infarction, coronary spasm, and unstable angina are the five types of myocardial infarction.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4585
Competitive Landscape:
Major players operating in the global myocardial infarction market include, AstraZeneca plc, Bristol-Myers Squibb Co., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Co Ltd., Johnson & Johnson Services Inc., Merck KGaA, Novartis International AG, Pfizer Inc., and Sanofi S.A.
Key Market Drivers:
Approval and launch of new drugs is expected to propel growth of the global myocardial infarction market over the forecast period. For instance, in April 2019, The U.S. Food and Drug Administration approved Praluent (alirocumab) to reduce the risk of heart attack, stroke, and unstable angina in adults with established cardiovascular disease.
R&D of new drugs is also expected to aid in growth of the market. For instance, in March 2021, Faraday Pharmaceuticals, Inc. reached special protocol agreement with the U.S. Food and Drug Administration the FDA for its Phase 3 study to assess FDY-5301 for the treatment of acute ST-segment elevation myocardial infarction.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4585
Covid-19 Impact Analysis
Globally, as of 5:51pm CET, 2 December 2021, there have been 262,866,050 confirmed cases of COVID-19, including 5,224,519 deaths, reported to WHO. As of 30 November 2021, a total of 7,885,790,810 vaccine doses have been administered. COVID-19 is a risk factor for myocardial infarction. The risk is high for individuals with or without a prior cardiovascular diagnosis. Evidence of myocardial injury is common among patients hospitalized with COVID-19.
Key Takeaways
Major players operating in the global myocardial infarction market are focused on R&D to expand their product portfolio. For instance, in June 2021, Idorsia Ltd. initiated the Phase 3 study to assess the efficacy and safety of self-administered subcutaneous selatogrel, Idorsia’s P2Y12 receptor antagonist, for the treatment of acute myocardial infarction.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4585
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
- Market Dynamics
- Global Myocardial Infarction Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Myocardial Infarction Treatment
- Impact of COVID-19 on the overall Healthcare Sector
- Global Myocardial Infarction Market, By Drug Class, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Antiplatelet Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Glycoprotein IIb/IIIa Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Antithrombotic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Beta-adrenergic Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Vasodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Angiotensin-converting Enzyme (ACE) Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Angiotensin-receptor Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Thrombolytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Myocardial Infarction Market, By Route of Administration, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Myocardial Infarction Market, By Distribution Channel, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837